Get started
Author

Jong‐Ha Lim

Observed name: Jong-Ha Lim
Observed institution: Ildong (South Korea)
ORCID: 0000-0003-0519-4951
Observed ORCID: 0000-0003-0519-4951
OpenAlex ID: A5049011219
Venadaparib Is a Novel and Selective PARP Inhibitor with Improved Physicochemical Properties, Efficacy, and Safety
2023 · Myongjae Lee, In-Gyu Je, et al. · Molecular Cancer Therapeutics · 15
PDF
First‐In‐Human Dose Finding Study of Venadaparib ( IDX ‐1197), a Potent and Selective PARP Inhibitor, in Patients With Advanced Solid Tumors
2025 · Sung‐Bae Kim, Kyun‐Seop Bae, et al. · Cancer Medicine · 4
PDF
Supplementary Data from Venadaparib Is a Novel and Selective PARP Inhibitor with Improved Physicochemical Properties, Efficacy, and Safety
2025 · Myongjae Lee, In-Gyu Je, et al.
Supplementary Data from Venadaparib Is a Novel and Selective PARP Inhibitor with Improved Physicochemical Properties, Efficacy, and Safety
2023 · Myongjae Lee, In-Gyu Je, et al.
Data from Venadaparib Is a Novel and Selective PARP Inhibitor with Improved Physicochemical Properties, Efficacy, and Safety
2023 · Myongjae Lee, In-Gyu Je, et al.
Works count: 5
Citation count: 19
H-index: 2
I10-index: 1
Year
Topic
Type